Human papillomavirus (HPV) vaccines in adults: Learnings from long-term follow-up of quadrivalent HPV vaccine clinical trials

The risk for acquiring human papillomavirus (HPV) infections and associated diseases is lifelong. An important part of prophylactic HPV vaccine development is durable protection against infection and disease. With comprehensive long-term follow-up (LTFU) in adolescents, men, and women, the quadrival...

Descripción completa

Detalles Bibliográficos
Autor principal: Goldstone, Stephen E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
HPV
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038021/
https://www.ncbi.nlm.nih.gov/pubmed/36916016
http://dx.doi.org/10.1080/21645515.2023.2184760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038021/
https://www.ncbi.nlm.nih.gov/pubmed/36916016
http://dx.doi.org/10.1080/21645515.2023.2184760

Ejemplares similares